Like everyone here, I would be absolutely ecstatic if we could get an approval based on the FIH and EFS studies but I don't think there's any conceivable chance that will happen.
Edwards is running a 915 patient trial to get the updated version of its Sapien device approved and it's a revised version of an already approved valve. No way will the FDA let a novel valve take a shortcut.
The number 1 priority of the FDA is safety and these are life-sustaining devices so they are expected to show that they are safe by completing sufficiently powered trials, which require large patient populations.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
AVR
anteris technologies global corp.
Add to My Watchlist
0.00%
!
$6.00

Like everyone here, I would be absolutely ecstatic if we could...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.00 |
Change
0.000(0.00%) |
Mkt cap ! $92.99M |
Open | High | Low | Value | Volume |
$6.00 | $6.06 | $6.00 | $12.63K | 2.093K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 83 | $6.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.09 | 1690 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 83 | 6.000 |
2 | 342 | 5.860 |
2 | 625 | 5.850 |
1 | 857 | 5.830 |
1 | 344 | 5.800 |
Price($) | Vol. | No. |
---|---|---|
6.090 | 1690 | 1 |
6.100 | 927 | 2 |
6.140 | 1490 | 1 |
6.150 | 218 | 1 |
6.160 | 92 | 1 |
Last trade - 11.30am 24/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |